Homepage ADVERTISEMENT 07-28-2021
Vietnam packages first 30,000 doses of Russian Covid-19 vaccine
Thursday,  7/22/2021, 12:17 

Vietnam packages first 30,000 doses of Russian Covid-19 vaccine

The Saigon Times

Russia’s Sputnik V Covid-19 vaccine. Vietnam has packaged the first 30,000 doses of Russia’s Sputnik V Covid-19 vaccine - PHOTO: VNA

HCMC - Vietnam has processed and packaged the first test batch of 30,000 doses of Russia’s Sputnik V Covid-19 vaccine, the Russian Direct Investment Fund (RDIF) and Company for Vaccine and Biological Production No.1 (Vabiotech) said on July 21.

Some 10,000 doses from the test batch will be shipped to the Gamaleya Center in Russia for quality checks. The quality check result from the Russian side will be available within 30 days, the local media reported.

If the doses are verified as standard and safe, the two sides will cut a deal to package the vaccine in Vietnam with a capacity of five million per month.

Earlier on March 23, Vietnam approved Russia’s Sputnik V Covid-19 vaccine for emergency use.

Kirill Dmitriev, CEO of RDIF, said that the fund and Vabiotech were closely cooperating with each other during the technology transfer process to help Vietnamese people gain easier access to the Sputnik V vaccine.

As the pandemic remains complicated and several new Covid-19 variants have appeared, RDIF is ramping up the production of the vaccine to speed up vaccination, he added.

Vabiotech Chairman Do Tuan Dat said that the cooperation between RDIF and Vabiotech was expected to provide Vietnam and Southeast Asian countries with the high-quality Covid-19 vaccine at reasonable prices.

Earlier, the Minister of Health had assigned Vabiotech, a State-owned enterprise under the ministry, to import semi-finished products and package the Sputnik V vaccine from early July, with a capacity of five million doses per month.

Besides, the packaging capacity will be raised to 100 million doses per year. In addition, Vietnam will continue working with the Russian side to receive production technology and build a production plant.

The Sputnik V vaccine, developed by the Gamaleya National Center of Epidemiology and Microbiology, is being used in 68 countries worldwide.

Share:
   
Others
>>Read more:
© 2016 - 2020 The Saigon Times.